** Shares of dermatology solutions company Cutera Inc
CUTR.O fall 19.5% to $32.55
** Co lowers revenue forecast to range between $252 million
and $253 million for full year 2022 from prior forecast of $255
million to $260 million.
** Co plans to release full results for Q4 and fiscal year
ended Dec. 31, 2022 after market close on Feb. 28
** All 5 brokerages rate the stock "buy" or higher; their
median PT is $70
** Co gained ~7% last year
(Reporting by Sriparna Roy)
((Sriparna.Roy@thomsonreuters.com;))